Thermo Fisher Scientific | TMO - Operating Profit

Stock Price
542.72
Daily Change
0.36 0.07%
Monthly
-12.06%
Yearly
-5.03%
Q1 Forecast
560.79

Thermo Fisher Scientific reported $2.3B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Agilent USD 443M 66M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Bio-Rad Laboratories USD 77.1M 53.4M Jun/2025
Boston Scientific USD 1.24B 203M Dec/2025
Bruker USD 83.9M 72M Sep/2025
Charles River Laboratories USD 133.8M 1.46M Sep/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 512M 401M Sep/2025
Edwards Lifesciences USD 425.1M 5.8M Sep/2025
Exact Sciences USD -25M 22.85M Sep/2025
General Electric Aerospace USD 1.77B 536M Dec/2025
Henry Schein USD 198M 22M Sep/2025
Hologic USD 237M 16M Dec/2025
Illumina USD 256M 6M Dec/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratory Of America USD 397.3M 65.5M Sep/2025
Medtronic USD 1.7B 100M Sep/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Myriad Genetics USD -23.3M 10.8M Sep/2025
Olympus JPY 33.57B 17.21B Sep/2025
Quest Diagnostics USD 386M 52M Sep/2025
Repligen USD 12.68M 6.72M Sep/2025
Revvity USD 98.34M 8.63M Sep/2025
Stryker USD 1.97B 609M Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veracyte USD 23.11M 8.8M Sep/2025
Waters USD 192.11M 3.9M Sep/2025
Zimmer Biomet Holdings USD 338.3M 58.1M Sep/2025